First Manhattan’s BioLife Solutions BLFS Stock Holding History

First Manhattan’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,085	Closed	-$51K	–	1298
2019 Q3	$51K	Hold	3,085	–	–	﹤0.01%	908
2019 Q2	$52K	Hold	3,085	–	–	﹤0.01%	931
2019 Q1	$55K	Hold	3,085	–	–	﹤0.01%	933
2018 Q4	$37K	Sell	3,085 -1,915	-38%	-$22.9K	﹤0.01%	973
2018 Q3	$87K	Sell	5,000 -7,000	-58%	-$138K	﹤0.01%	871
2018 Q2	$136K	Hold	12,000	–	–	﹤0.01%	761
2018 Q1	$61K	Hold	12,000	–	–	﹤0.01%	918
2017 Q4	$72K	Buy	+12,000	New	+$69.1K	﹤0.01%	927

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SCM

Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

First Manhattan's BLFS Position: Q4 2019 in Review

First Manhattan sold out of BioLife Solutions (BLFS) in Q4 2019, closing a stake of 3,085 shares — an estimated $51K sold.

First Manhattan first reported a position in BLFS in Q4 2017 and held it in 8 quarters. The position peaked at $136K in Q2 2018. 80 funds tracked by Wall St. Rank hold BLFS as of Q4 2019.

First Manhattan reported no remaining BioLife Solutions position as of Q4 2019 after selling out during the quarter.
First Manhattan sold 3,085 BioLife Solutions shares in Q4 2019, an estimated $51K.
First Manhattan first reported a position in BioLife Solutions in Q4 2017 and held it in 8 quarters.
First Manhattan's BioLife Solutions position peaked at $136K in Q2 2018.
80 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2019.

Based on First Manhattan's 13F filing for Q4 2019, filed 13 Feb 2020.